Citation Impact
Citing Papers
The Effect of Protein and Glycemic Index on Children's Body Composition: The DiOGenes Randomized Study
2010
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Incretin hormones and the satiation signal
2013
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
2009 Standout
The Epidemiology of Obesity: A Big Picture
2014 Standout
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
2013
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
2013
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Unraveling oxyntomodulin, GLP1's enigmatic brother
2012
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
The role of the gut/brain axis in modulating food intake
2011
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
2012 Standout
Progress and challenges in anti-obesity pharmacotherapy
2017
Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
2014
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
2015 Standout
Management of obesity
2016
Future directions for peptide therapeutics development
2013
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
2022
Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men
2011 Standout
A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes
2012
Fibrosis and Adipose Tissue Dysfunction
2013 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The causes of porotic hyperostosis and cribra orbitalia: A reappraisal of the iron‐deficiency‐anemia hypothesis
2009 Standout
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
Trend in Obesity Prevalence in European Adult Cohort Populations during Follow-up since 1996 and Their Predictions to 2015
2011
Inhibition by Natural Dietary Substances of Gastrointestinal Absorption of Starch and Sucrose in Rats and Pigs: 1. Acute Studies
2007
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Coronavirus envelope protein: current knowledge
2019 Standout
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
2015
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Type 2 diabetes
2017 Standout
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension
2012
Management of obesity: improvement of health-care training and systems for prevention and care
2015
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
The Future of Peptide‐based Drugs
2012 Standout
Peptide therapeutics: current status and future directions
2014 Standout
Needle and surgical biopsy techniques differentially affect adipose tissue gene expression profiles
2008
Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis
2018
New Medications for Treatment of Obesity: Metabolic and Cardiovascular Effects
2014
Short-chain fatty acids in control of body weight and insulin sensitivity
2015 Standout
Type 2 diabetes mellitus
2015 Standout
Effect of Exercise and Pharmacological Interventions on Visceral Adiposity: A Systematic Review and Meta-analysis of Long-term Randomized Controlled Trials
2019
Polycystic ovary syndrome
2016 Standout
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
2019 Standout
European Guidelines for Obesity Management in Adults
2015 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
What's in a Word? On Weight Stigma and Terminology
2016 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
2016
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
2016
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Trends in Obesity Among Adults in the United States, 2005 to 2014
2016 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Variations in the Prevalence of Obesity Among European Countries, and a Consideration of Possible Causes.
2017 Standout
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
2013
Cardiovascular Biology of the Incretin System
2012
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
2016
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Current and emerging medications for overweight or obesity in people with comorbidities
2015
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
2015
The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
2013
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Interventions for preventing obesity in children
2019 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Nutritional status of vegetarian children
1982
Versatile Peptide C-Terminal Functionalization via a Computationally Engineered Peptide Amidase
2016 StandoutNobel
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
2015
The Science of Obesity Management: An Endocrine Society Scientific Statement
2018
Fruit and vegetable intakes and subsequent changes in body weight in European populations: results from the project on Diet, Obesity, and Genes (DiOGenes)
2009
Surgery for weight loss in adults
2014 Standout
Long-term Drug Treatment for Obesity
2013
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
2015
Cardiovascular Actions of Incretin-Based Therapies
2014
Cardiovascular and Metabolic Heterogeneity of Obesity
2018
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults
2018
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of A E Harper being referenced
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
2011
DiOGenes: a multidisciplinary offensive focused on the obesity epidemic
2005
Can we advise our obese patients to follow the Atkins diet?
2004
Dietary goals — a skeptical view
1978